idarubicin has been researched along with Cancer of Skin in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.67) | 18.7374 |
1990's | 5 (33.33) | 18.2507 |
2000's | 2 (13.33) | 29.6817 |
2010's | 7 (46.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aragüés, M; Chicharro, P; Fraga, J; Llamas-Velasco, M; Reolid, A; Rodríguez-Jiménez, P | 1 |
Aqel, N; Ayto, R; Camilleri, M; Griffin, JC; Siow, W | 1 |
Hebeda, KM; Janssen, NA; Stevens, WB; van der Velden, WJ | 1 |
Koning, GA; Lokerse, WJM; Lu, T; Seynhaeve, ALB; Ten Hagen, TLM | 1 |
Alexander, C; Bashford, J; Jefferies, PD; Lee, GA; Whitehead, K | 1 |
Choi, MJ; Kim, HO; Kim, HS; Park, YM | 1 |
Hsu, CH; Liu, CI | 1 |
Bastida, J; Carretero, G; Medina, C; Santana, N; Valerón-Almazán, P; Vilar, J | 1 |
McKenna, KE; Morris, TC; Ramadan, KM | 1 |
Catalano, L; Frigeri, F; Luciano, L; Notaro, R; Pane, F; Rotoli, B; Salvatore, F; Santoro, LE; Selleri, C | 1 |
Estey, E; Kuschel, B | 1 |
Görg, C; Havemann, K; Köppler, H; Pflüger, KH; Wacker, HH; Weide, R | 1 |
Bernengo, MG; Doveil, GC; Fierro, MT; Quaglino, P; Savoia, P; Verrone, A | 1 |
Biondi, A; Coppi, MR; Liso, V; Mestice, A; Mininni, D; Palumbo, G; Pogliani, EM; Rossi, V; Specchia, G; Teruzzi, E | 1 |
Di Lauro, L; Di Pietro, N; Ganzina, F; Lazzaro, B; Lopez, M; Papaldo, P | 1 |
1 review(s) available for idarubicin and Cancer of Skin
Article | Year |
---|---|
Leukemic Vasculitis: Case Report and Review of the Literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Marrow Transplantation; Colitis, Ulcerative; Cytarabine; Diagnosis, Differential; Erythema; Female; Humans; Idarubicin; Immunohistochemistry; Leg Dermatoses; Leukemia, Myeloid, Acute; Leukemic Infiltration; Mesalamine; Skin Neoplasms; Transplantation Conditioning; Treatment Outcome; Vasculitis | 2019 |
14 other study(ies) available for idarubicin and Cancer of Skin
Article | Year |
---|---|
Blastic plasmacytoid dendritic cell neoplasm: a pathological illustration of two clinical cases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Dendritic Cells; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Lymphatic Metastasis; Male; Myeloproliferative Disorders; Recurrence; Skin Neoplasms; Vidarabine | 2017 |
A "body armor" of leukemia cutis.
Topics: Adult; Antineoplastic Agents; Cell Movement; Daunorubicin; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid, Acute; Recurrence; Remission Induction; Sarcoma, Myeloid; Skin; Skin Neoplasms; Transplantation, Homologous | 2015 |
Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Dose-Response Relationship, Drug; Doxorubicin; Drug Compounding; Drug Stability; Humans; Hydrogen-Ion Concentration; Hyperthermia, Induced; Idarubicin; Kinetics; Lipids; Liposomes; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Nude; Polyethylene Glycols; Skin Neoplasms; Solubility; Temperature; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Life-threatening conjunctival presentation of myeloid sarcoma.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Conjunctival Neoplasms; Cytarabine; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Middle Aged; Neoplasms, Second Primary; Sarcoma, Myeloid; Skin Neoplasms | 2008 |
Leukemia cutis limited to the needle puncture sites.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cytarabine; Fatal Outcome; Humans; Idarubicin; Leukemia, Myeloid, Acute; Leukemic Infiltration; Male; Skin Neoplasms | 2010 |
Leukaemia cutis at the site of striae distensae: an isotopic response?
Topics: Antineoplastic Combined Chemotherapy Protocols; Atrophy; Biopsy; Cytarabine; Female; Humans; Idarubicin; Leukemia; Middle Aged; Skin; Skin Diseases; Skin Neoplasms; Treatment Outcome | 2010 |
Utility of myeloperoxidase stain in the differential diagnosis of leukemia cutis vs. hystiocitoid Sweet syndrome.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cytarabine; Diagnosis, Differential; Humans; Idarubicin; Leukemia, Myeloid, Acute; Leukemic Infiltration; Male; Peroxidase; Skin; Skin Neoplasms; Staining and Labeling; Sweet Syndrome; Treatment Outcome | 2011 |
Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Clarithromycin; Dexamethasone; Diphosphonates; Glomerulonephritis; Humans; Idarubicin; Imidazoles; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Pamidronate; Protein Synthesis Inhibitors; Pyrazines; Skin Neoplasms; Thalidomide; Zoledronic Acid | 2006 |
All-trans-retinoic acid (ATRA) responsive skin relapses of acute promyelocytic leukaemia followed by ATRA-induced pseudotumour cerebri.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Blotting, Southern; Cytarabine; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Molecular Sequence Data; Polymerase Chain Reaction; Pseudotumor Cerebri; Skin Neoplasms; Tretinoin | 1996 |
Isolated leukemia cutis and CNS involvement in combination with cytogenetic findings of trisomy 8--two case reports.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Central Nervous System Neoplasms; Chromosomes, Human, Pair 8; Cytarabine; Drug Resistance, Neoplasm; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Middle Aged; Skin Neoplasms; Trisomy; Vidarabine | 1995 |
Cutaneous monoblastic leukemia as a first sign of relapse six years after autologous bone marrow transplantation for acute leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Cytarabine; Female; Humans; Idarubicin; Leukemia, Monocytic, Acute; Middle Aged; Recurrence; Skin; Skin Neoplasms; Time Factors; Transplantation, Autologous | 1996 |
Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Prednisone; Remission Induction; Sezary Syndrome; Skin Neoplasms; Vincristine | 1997 |
Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Cytarabine; Daunorubicin; Disease Progression; Fatal Outcome; Female; Gene Amplification; Gene Rearrangement; Humans; Idarubicin; Immunophenotyping; Leukemia, Promyelocytic, Acute; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Skin Neoplasms; Translocation, Genetic; Tretinoin | 1998 |
Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Drug Evaluation; Hematologic Diseases; Humans; Idarubicin; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Skin Neoplasms | 1986 |